Application of nanoparticles to reverse multi-drug resistance in cancer

被引：7

作者：

Yang, Jie ^{[1
]}

Zhang, Haijun ^{[1
]}

Chen, Baoan ^{[1
]}

机构：

[1] Southeast Univ, Sch Med, Zhongda Hosp, Dept Hematol & Oncol, Nanjing 210009, Jiangsu, Peoples R China

来源：

NANOTECHNOLOGY REVIEWS | 2016年 / 5卷 / 05期

关键词：

cancer; multi-drug resistance (MDR); nanoparticles (NPs); MESOPOROUS SILICA NANOPARTICLES; OVERCOME DRUG-RESISTANCE; VINCRISTINE SULFATE DELIVERY; SOLID LIPID NANOPARTICLES; BREAST-CANCER; CO-DELIVERY; MULTIFUNCTIONAL NANOPARTICLES; IN-VITRO; MAGNETIC NANOPARTICLES; HYALURONIC-ACID;

D O I：

10.1515/ntrev-2016-0023

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Multi-drug resistance (MDR) poses a large obstacle to various human malignancies. For a long period, combination of multiple therapeutic agents has been the conventional method used to reverse MDR in cancer. However, it is still not an effective method as rather than cancer its serious side effects causes patient's death. Nanoparticles (NPs) are emerging as a class of therapeutics for cancer, including overcoming MDR. In the present review, we focus on the application of NPs to reverse MDR in cancer. Several kinds of NPs developed for the reversal of MDR are summarized. In addition, investigations in vitro and in vivo are also shown to highlight the advancement in the application of NPs to reverse MDR.

引用

页码：489 / 496

页数：8

共 50 条

[21] Application of Nanoparticles for Efficient Delivery of Quercetin in Cancer Cells
Homayoonfal, Mina
Aminianfar, Azadeh
Asemi, Zatollah
Yousefi, Bahman
CURRENT MEDICINAL CHEMISTRY, 2024, 31 (09) : 1107 - 1141
[22] Applications of Nanotechnology-based Approaches to Overcome Multi-drug Resistance in Cancer
Kalave, Sana
Hegde, Namita
Juvale, Kapil
CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (38) : 3140 - 3157
[23] The association of a genetic variant in multi-drug resistance gene and colorectal cancer susceptibility
Amerizadeh, Forouzan
Moetamani-Ahmadi, Mehrdad
Shahidsales, Soodabeh
Rahmani, Farzad
Gharib, Masoumeh
Hosseini, Tooba Mohammad
Ziaeemehr, Aghigh
Ahmadi-Simab, Saeideh
Ferns, Gordon A.
Talebi, Mahdi
Avan, Amir
GENE REPORTS, 2021, 24
[24] Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells
Li, Yan
Revalde, Jezrael L.
Reid, Glen
Paxton, James W.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 603 - 610
[25] Conquering Cancer Multi-Drug Resistance Using Curcumin and Cisplatin Prodrug-Encapsulated Mesoporous Silica Nanoparticles for Synergistic Chemo- and Photodynamic Therapies
Busa, Prabhakar
Kankala, Ranjith Kumar
Deng, Jin-Pei
Liu, Chen-Lun
Lee, Chia-Hung
NANOMATERIALS, 2022, 12 (20)
[26] Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multi-drug resistance
Kaushik, Lokesh
Srivastava, Shubham
Panjeta, Anshul
Chaudhari, Dasharath
Ghadi, Rohan
Kuche, Kaushik
Malik, Ruchi
Preet, Simran
Jain, Sanyog
Raza, Kaisar
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 578
[27] Topotecan-Loaded Mesoporous Silica Nanoparticles for Reversing Multi-Drug Resistance by Synergetic Chemoradiotherapy
Shen, Bo
Zhao, Kuaile
Ma, Shulan
Yuan, Dexiao
Bai, Yang
CHEMISTRY-AN ASIAN JOURNAL, 2015, 10 (02) : 344 - 348
[28] A novel chitosan-based nanomedicine for multi-drug resistant breast cancer therapy
Niu, Shiwei
Williams, Gareth R.
Wu, Jianrong
Wu, Junzi
Zhang, Xuejing
Zheng, Hong
Li, Shude
Zhu, Li-Min
CHEMICAL ENGINEERING JOURNAL, 2019, 369 : 134 - 149
[29] Synergistic effect of paclitaxel and verapamil to overcome multi-drug resistance in breast cancer cells
Li, Peng
Zhong, Di
Gong, Pei-yao
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 516 (01) : 183 - 188
[30] Formulation Strategy to Overcome Multi-Drug Resistance (MDR)
Cho, Cheong-Weon
ARCHIVES OF PHARMACAL RESEARCH, 2011, 34 (04) : 511 - 513

← 1 2 3 4 5 →